logo-loader
AIM:C4XD

C4X Discovery Holdings PLC

Receive alerts
Market:
AIM
Price
9.40 GBX
Day Change
-6.00%
Market Cap:
£23.71 m
52 weeks high
22.00
52 weeks low
7.60

In brief

C4X Discovery Holdings PLC is a pioneering drug discovery company combining scientific expertise with cutting-edge drug discovery technologies to efficiently deliver world leading medicines.

The company has a highly valuable and differentiated approach to drug discovery through its enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, oncology, neurodegeneration and addictive disorders.

C4X Discovery's commercially attractive portfolio ranges from early-stage novel target opportunities to late-stage drug discovery programmes ready for out-licensing to partners and it has two commercially partnered programmes with one candidate in clinical development.

Snapshot

  • C4X Discovery CEO says delisting decision not taken lightly
  • C4X Discovery succeeding in the face of some tough market headwinds
  • C4X Discovery payment ‘strong validation’ of firm’s prowess - analyst
  • C4X Discovery "really well capitalised and focused" heading into new year